Literature DB >> 3114875

Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis.

M Seitz, I Napierski, R Augustin, W Hunstein, H Kirchner.   

Abstract

Tests for lymphoproliferation and interferon induction in normal blood donors and patients with rheumatoid arthritis (RA) were performed in a whole-blood assay. Patients with high inflammatory RA showed significantly reduced lymphoproliferation and interferon gamma production after stimulation with phytohemagglutinin (PHA) and concanavalin A (Con A) when compared with patients with low inflammatory activity, or with normal control individuals. Similarly, patients with high and low inflammatory RA exhibited a significantly reduced interferon alpha production after stimulation with Newcastle Disease Virus (NDV) when compared with normal blood donors. Our findings may point to an important immunodeficiency of the circulating lymphocytes of RA patients and may explain some of the in vitro immunoregulatory abnormalities reported in this disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114875     DOI: 10.3109/03009748709102926

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

Review 1.  T cell regulation and T cell clones in relation to synovial inflammation.

Authors:  G R Burmester; B Jahn; N Hain; G Strobel; J R Kalden
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha.

Authors:  V A Danis; A J Kulesz; D S Nelson; P M Brooks
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Effects of interferon gamma on cultured synovial cells from patients with rheumatoid arthritis: inhibition of cell growth, prostaglandin E2, and collagenase release.

Authors:  H Nakajima; Y Hiyama; W Tsukada; H Warabi; S Uchida; S Hirose
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

4.  A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients.

Authors:  S J Fokkema; B G Loos; C Slegte; U van der Velden
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

5.  Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.

Authors:  R Nissinen; M Leirisalo-Repo; R Peltomaa; T Palosuo; O Vaarala
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

6.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Depressed PPD and tetanus toxoid presentation by monocytes to T lymphocytes in patients with rheumatoid arthritis: restoration by interferon gamma.

Authors:  M Seitz; I Napierski; H Kirchner
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

8.  Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.

Authors:  G Horneff; U Sack; J R Kalden; F Emmrich; G R Burmester
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

9.  Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists.

Authors:  Gulen Hatemi; Melike Melikoglu; Fatma Ozbakir; Koray Tascilar; Hasan Yazici
Journal:  Arthritis Res Ther       Date:  2012-06-18       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.